Literature DB >> 22939588

Association of circulating adiponectin with testosterone in women during the menopausal transition.

Sumika Matsui1, Toshiyuki Yasui, Anna Tani, Takeshi Kato, Kotaro Kunimi, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki, Minoru Irahara.   

Abstract

OBJECTIVE: We examined (1) the change in circulating adiponectin in women during the menopausal transition and (2) the associations of adiponectin levels with estrogen, androgen and sex hormone-binding globulin (SHBG) in women during the menopausal transition.
METHODS: We conducted a cross-sectional study in 235 healthy women and divided them into 7 stages by menstrual regularity and follicle-stimulating hormone (FSH) level. Serum levels of adiponectin, estradiol, total testosterone, dehydroepiandrosterone-sulfate (DHEA-S) and SHBG were measured. Levels of free and bioavailable testosterone were calculated by using total testosterone, albumin and SHBG.
RESULTS: Serum adiponectin levels showed a U-curve, levels being low in early and late menopausal transition and gradually becoming higher after menopause. Adiponectin levels were negatively correlated with levels of free testosterone, bioavailable testosterone and DHEA-S and were positively correlated with SHBG in postmenopausal women for whom more than 1 year had passed since menopause. Adiponectin level was not correlated with estradiol level.
CONCLUSION: Circulating adiponectin level shows a U-curve during the menopausal transition and adiponectin level is associated with levels of free and bioavailable testosterone and DHEA-S in postmenopause.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939588     DOI: 10.1016/j.maturitas.2012.08.003

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  7 in total

1.  Difference in the ratio of high-molecular weight (HMW) to total adiponectin and HMW adiponectin in late post-menopausal women.

Authors:  S Matsui; T Yasui; A Tani; T Kato; K Kunimi; H Uemura; A Kuwahara; T Matsuzaki; M Irahara
Journal:  J Endocrinol Invest       Date:  2013-06-10       Impact factor: 4.256

Review 2.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

3.  Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.

Authors:  Grace Huang; Elizabeth Tang; Adam Aakil; Stephan Anderson; Hernan Jara; Maithili Davda; Helene Stroh; Thomas G Travison; Shalender Bhasin; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

Review 4.  Vascular endothelial adiponectin signaling across the life span.

Authors:  Katie E Cohen; Boran Katunaric; Gopika SenthilKumar; Jennifer J McIntosh; Julie K Freed
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

5.  Adiposity distribution influences circulating adiponectin levels.

Authors:  Mitchell Guenther; Roland James; Jacqueline Marks; Shi Zhao; Aniko Szabo; Srividya Kidambi
Journal:  Transl Res       Date:  2014-04-18       Impact factor: 7.012

6.  Gender differences in adiponectin levels and body composition in older adults: Hallym aging study.

Authors:  Hong Ji Song; Sohee Oh; Shanai Quan; Ohk-Hyun Ryu; Jin-Young Jeong; Kyung-Soon Hong; Dong-Hyun Kim
Journal:  BMC Geriatr       Date:  2014-01-25       Impact factor: 3.921

Review 7.  Adiponectin as a biomarker of osteoporosis in postmenopausal women: controversies.

Authors:  Anna Lubkowska; Aleksandra Dobek; Jan Mieszkowski; Wojciech Garczynski; Dariusz Chlubek
Journal:  Dis Markers       Date:  2014-01-23       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.